Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...

Researchers have developed a blood-based diagnostic method for multiple myeloma and its precursor conditions. The method ...

The market’s growth is largely powered by the ongoing advancements and widespread adoption of key technologies, particularly Fluorescent In Situ Hybridization (FISH). In 2025, FISH is estimated to be ...

Fluorescence in situ hybridisation (FISH) has long been established as an indispensable molecular tool for the detection, localisation and quantification of nucleic acids within their native ...

The global market for In Situ Hybridization (ISH) estimated at US$908 Million in the year 2022, is projected to reach a revised size of US$1.5 Billion by 2030, growing at a CAGR of 6.6% over the ...

The Asia Pacific in situ hybridization market is projected to reach USD 744 million by 2027 from USD 363 million in 2022, at a CAGR of 15.4% during the forecast period. Companion diagnostic ...

Researchers tested more than 65,000 patients with more than 30 solid tumor types and found the rate of HER2 positivity was about 3%.

The global in situ hybridization market is primed for a decade of remarkable expansion, fueled by its increasing adoption in both research and clinical domains. According to a recent report by Future ...